Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH – Get Free Report)’s share price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. Anthera Pharmaceuticals shares last traded at $0.00, with a volume of 47,717 shares traded.
Anthera Pharmaceuticals Stock Up 9,900.0 %
About Anthera Pharmaceuticals
Anthera Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy.
Read More
- Five stocks we like better than Anthera Pharmaceuticals
- How to Short Nasdaq: An Easy-to-Follow Guide
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- 5 Top Rated Dividend Stocks to Consider
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Anthera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
